Correlation Between Acurx Pharmaceuticals and Tiziana Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Acurx Pharmaceuticals and Tiziana Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acurx Pharmaceuticals and Tiziana Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acurx Pharmaceuticals LLC and Tiziana Life Sciences, you can compare the effects of market volatilities on Acurx Pharmaceuticals and Tiziana Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acurx Pharmaceuticals with a short position of Tiziana Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acurx Pharmaceuticals and Tiziana Life.

Diversification Opportunities for Acurx Pharmaceuticals and Tiziana Life

0.25
  Correlation Coefficient

Modest diversification

The 3 months correlation between Acurx and Tiziana is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Acurx Pharmaceuticals LLC and Tiziana Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tiziana Life Sciences and Acurx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acurx Pharmaceuticals LLC are associated (or correlated) with Tiziana Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tiziana Life Sciences has no effect on the direction of Acurx Pharmaceuticals i.e., Acurx Pharmaceuticals and Tiziana Life go up and down completely randomly.

Pair Corralation between Acurx Pharmaceuticals and Tiziana Life

Given the investment horizon of 90 days Acurx Pharmaceuticals LLC is expected to under-perform the Tiziana Life. But the stock apears to be less risky and, when comparing its historical volatility, Acurx Pharmaceuticals LLC is 1.65 times less risky than Tiziana Life. The stock trades about -0.4 of its potential returns per unit of risk. The Tiziana Life Sciences is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  99.00  in Tiziana Life Sciences on August 28, 2024 and sell it today you would lose (3.00) from holding Tiziana Life Sciences or give up 3.03% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Acurx Pharmaceuticals LLC  vs.  Tiziana Life Sciences

 Performance 
       Timeline  
Acurx Pharmaceuticals LLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Acurx Pharmaceuticals LLC has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Tiziana Life Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tiziana Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Acurx Pharmaceuticals and Tiziana Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Acurx Pharmaceuticals and Tiziana Life

The main advantage of trading using opposite Acurx Pharmaceuticals and Tiziana Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acurx Pharmaceuticals position performs unexpectedly, Tiziana Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tiziana Life will offset losses from the drop in Tiziana Life's long position.
The idea behind Acurx Pharmaceuticals LLC and Tiziana Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance